A gastric cancer cell model of the signaling pathway of anticancer drug-induced apoptotic cell death suggests that increased AP-1 activity plays an important role and is associated with Gadd153 induction, regardless of the p53 genotype [118]. The gene discussed is TP53; the disease is gastric cancer.